Some Thoughts on the Upgrade of Working Meal
Release time:
2020-07-22
Thoughts on the Upgrade of Working Meal
One dish and one meal are always related. The increase in food in the canteen and the increase in food subsidies seem to be just a "small thing" of 100 or 200 yuan per person per month, but when it is enlarged to 1000 or 2000 employees of the entire group, it becomes a large number. The "overweight" of the working meal is the most direct response of the company to the problems reflected by the employees, and it also reflects the consistent "people-oriented" attitude of the peak since its inception.
In fact, everyone knows that the staff canteen is a thankless errand-it is difficult for everyone to adjust, and everyone can never be satisfied. In the past, when the canteen was tidying up after a meal, it was often seen that large pieces of rice were mixed in the swill bucket, or steamed buns that had not been bitten. Although it is no longer the "year" when there was not enough to eat, such unnecessary waste is really painful. The ancients said, "One porridge and one meal should be hard-won; half a thread and half a thread, constant thoughts and material strength are difficult." Although only half a bowl of rice and a piece of steamed bread were dumped, it reflected people's literacy and ideological understanding.
"Looking at the former sage country and family, success is broken by thrift and extravagance", so is the family country, so is the enterprise. Enterprises to operate and develop, reduce operating costs, reduce unnecessary expenses is the inevitable prerequisite to participate in market competition. Every profit of the enterprise and every welfare given to the employees are condensed with our own sweat. The idea that "it's public anyway, it doesn't matter if it's wasted" is actually a disrespect for one's own labor. To achieve high-quality development, we also need to start from a small place of porridge, a meal, a piece of paper, and a kilowatt-hour of electricity, to be responsible for the company, to be responsible for our own behavior, so that every bit of wealth we create can be maximized. value. At the same time, we should also give more play to our ingenuity and make every minute of labor create more wealth. As a member of the spike, only when our enterprises have more profits can we enjoy better benefits. (one word)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31